Shaun Carter
Keine laufenden Positionen mehr
Profil
Shaun Carter worked as a Group Development & Strategy Director at Intersect ENT, Inc. and as a Director-Group Development & Strategy at Carillion Plc.
He holds an MBA from Warwick Business School.
Ehemalige bekannte Positionen von Shaun Carter
| Unternehmen | Position | Ende |
|---|---|---|
| CARILLION PLC | Corporate Officer/Principal | 31.12.2017 |
| INTERSECT ENT, INC. | Corporate Officer/Principal | - |
Ausbildung von Shaun Carter
| Warwick Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARILLION PLC | Industrial Services |
| Private Unternehmen | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
